JPET Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 15, 2003; DOI: 10.1124/jpet.103.055095


0022-3565/03/3072-729-736$20.00
JPET 307:729-736, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.055095v1
307/2/729    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chi, L.
Right arrow Articles by Reith, M. E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chi, L.
Right arrow Articles by Reith, M. E. A.

CELLULAR AND MOLECULAR

Substrate-Induced Trafficking of the Dopamine Transporter in Heterologously Expressing Cells and in Rat Striatal Synaptosomal Preparations

Limen Chi, and Maarten E. A. Reith1

Department of Biomedical and Therapeutic Sciences, University of Illinois College of Medicine, Peoria, Illinois

Dopamine transporter (DAT) trafficking was assessed by functional measurements of dopamine uptake and by biotinylation of surface proteins followed by gel electrophoresis and Western blotting. In human embryonic kidney (HEK)-293 cells expressing human DAT (HEK-hDAT), pretreatment with dopamine (0.1-100 µM) followed by washout caused reductions in subsequent dopamine uptake (reflected in Vmax) with effective dopamine concentrations in the 10 to 100 µM range and pretreatment times of 10 to 60 min. Reductions assessed after 60-min pretreatment with 100 µM dopamine corresponded with decreases measured in surface DAT by the noncleavable biotin method, which were caused, at least in part, by enhanced endocytosis as monitored with cleavable biotin. Pretreatment of rat striatal synaptosomes with dopamine (10 and 100 µM) also caused reductions in DAT uptake activity (Vmax), and again the underlying mechanism seemed to be a diminished presence of DAT at the surface of synaptosomes as measured by the noncleavable biotin method. The copresence of cocaine during pretreatment with dopamine prevented the down-regulation of surface DAT. The present results show that DAT surface residency can be regulated by substrate acting on it, not only in cells heterologously expressing DAT but also in situ in rat brain tissue.


Received May 30, 2003; accepted July 29, 2003.

Address correspondence to: Dr. Maarten E. A. Reith, Department of Biomedical and Therapeutic Sciences, University of Illinois College of Medicine, Box 1649, Peoria, IL 61656-1649. E-mail: maartenr{at}uic.edu




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
Y. Wei, J. M. Williams, C. Dipace, U. Sung, J. A. Javitch, A. Galli, and C. Saunders
Dopamine Transporter Activity Mediates Amphetamine-Induced Inhibition of Akt through a Ca2+/Calmodulin-Dependent Kinase II-Dependent Mechanism
Mol. Pharmacol., March 1, 2007; 71(3): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Dipace, U. Sung, F. Binda, R. D. Blakely, and A. Galli
Amphetamine Induces a Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Reduction in Norepinephrine Transporter Surface Expression Linked to Changes in Syntaxin 1A/Transporter Complexes
Mol. Pharmacol., January 1, 2007; 71(1): 230 - 239.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Miranda, K. R. Dionne, T. Sorkina, and A. Sorkin
Three Ubiquitin Conjugation Sites in the Amino Terminus of the Dopamine Transporter Mediate Protein Kinase C-dependent Endocytosis of the Transporter
Mol. Biol. Cell, January 1, 2007; 18(1): 313 - 323.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Sorkina, M. Miranda, K. R. Dionne, B. R. Hoover, N. R. Zahniser, and A. Sorkin
RNA Interference Screen Reveals an Essential Role of Nedd4-2 in Dopamine Transporter Ubiquitination and Endocytosis
J. Neurosci., August 2, 2006; 26(31): 8195 - 8205.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. M. Kahlig, B. J. Lute, Y. Wei, C. J. Loland, U. Gether, J. A. Javitch, and A. Galli
Regulation of Dopamine Transporter Trafficking by Intracellular Amphetamine
Mol. Pharmacol., August 1, 2006; 70(2): 542 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Cervinski, J. D. Foster, and R. A. Vaughan
Psychoactive Substrates Stimulate Dopamine Transporter Phosphorylation and Down-regulation by Cocaine-sensitive and Protein Kinase C-dependent Mechanisms
J. Biol. Chem., December 9, 2005; 280(49): 40442 - 40449.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. G. Garcia, Y. Wei, J. A. Moron, R. Z. Lin, J. A. Javitch, and A. Galli
Akt Is Essential for Insulin Modulation of Amphetamine-Induced Human Dopamine Transporter Cell-Surface Redistribution
Mol. Pharmacol., July 1, 2005; 68(1): 102 - 109.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. D. Jayanthi, D. J. Samuvel, R. D. Blakely, and S. Ramamoorthy
Evidence for Biphasic Effects of Protein Kinase C on Serotonin Transporter Function, Endocytosis, and Phosphorylation
Mol. Pharmacol., June 1, 2005; 67(6): 2077 - 2087.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Wang and M. W. Quick
Trafficking of the Plasma Membrane {gamma}-Aminobutyric Acid Transporter GAT1: SIZE AND RATES OF AN ACUTELY RECYCLING POOL
J. Biol. Chem., May 13, 2005; 280(19): 18703 - 18709.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. J. Samuvel, L. D. Jayanthi, N. R. Bhat, and S. Ramamoorthy
A Role for p38 Mitogen-Activated Protein Kinase in the Regulation of the Serotonin Transporter: Evidence for Distinct Cellular Mechanisms Involved in Transporter Surface Expression
J. Neurosci., January 5, 2005; 25(1): 29 - 41.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Gates Jr., S. M. Ferguson, R. D. Blakely, and S. Apparsundaram
Regulation of Choline Transporter Surface Expression and Phosphorylation by Protein Kinase C and Protein Phosphatase 1/2A
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 536 - 545.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. A. Vaughan
Phosphorylation and Regulation of Psychostimulant-Sensitive Neurotransmitter Transporters
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-B. Li, N. Chen, S. Ramamoorthy, L. Chi, X.-N. Cui, L. C. Wang, and M. E. A. Reith
The Role of N-Glycosylation in Function and Surface Trafficking of the Human Dopamine Transporter
J. Biol. Chem., May 14, 2004; 279(20): 21012 - 21020.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.